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INTRODUCTION
Around the world there are >198,000 new cases of endo  me­
trial cancer (EC) per year and over 50,000 deaths [1] whilst in 
the USA there are >43,000 new cases and >7,900 deaths [2]. 
The primary treatment for EC is surgery and the Inter  na  tional 
Federation of Obstetrics and Gynecology (FIGO) staging sys­
tem is surgical [3]. Traditionally, the surgery has been by lapa­
rotomy but laparoscopic techniques are now widely used be­
cause of an improved morbidity profile for equivalent survival 
[4]. 
Originally, patients selected for laparoscopy for EC tended to 
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Objective: To determine the effect of body mass index on postoperative complications and the performance of lymph node 
dissection in women undergoing laparoscopy or laparotomy for endometrial cancer.
Methods: Retrospective chart review of all patients undergoing surgery for endometrial cancer between 8/2004 and 12/2008. 
Complications graded and analyzed using Common Toxicity Criteria for Adverse Events ver. 4.03 classification.
Results: 168 women underwent surgery: laparoscopy n=65, laparotomy n=103. Overall median body mass index 36.2 (range, 
18.1 to 72.7) with similar distributions for age, body mass index and performance of lymph node dissection between groups. 
Following laparoscopy vs. laparotomy the percent rate of overall complications 53.8:73.8 (p=0.01), grade ≥3 complications 
9.2:34.0 (p<0.01), ≥3 wound complications 3.1:22.3 (p<0.01) and ≥3 wound infection 3.1:20.4 (p=0.01) were significantly lower 
after laparoscopy. In a logistic model there was no effect of body mass index (≥36 and<36) on complications after laparoscopy 
in contrast to laparotomy. Para­aortic lymph node dissection was performed by laparoscopy 19/65 (29%): by laparotomy 34/103 
(33%) p=0.61 and pelvic lymph node dissection by laparoscopy 21/65 (32.3%): by laparotomy 46/103 (44.7%) p=0.11. Logistic 
regression analysis revealed that for patients undergoing laparoscopy for stage I disease there was an inverse relationship 
between the performance of both para­aortic lymph node dissection and pelvic lymph node dissection and increasing body 
mass index (p=0.03 and p<0.01 respectively) in contrast to the laparotomy group where there was a trend only (p=0.09 and 0.05).
Conclusion: For patients undergoing laparoscopy, increasing body mass index did not impact postoperative complications but 
did influence the decision to perform lymph node dissection.
Keywords: Body mass index, Endometrial cancer, Laparoscopy, Laparotomy, Obesity
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have lower body mass index (BMI) [5] but obese patients have 
been shown to gain the most from laparoscopy [6]. Obesity is 
not only a major risk factor for the development of EC [7] but 
it increases postoperative complications, especially wound 
infection, and is associated with factors such as hypertension, 
heart disease and diabetes which add additional surgical risk.
Despite the prevalence of obesity in EC, there are surpris­
ingly few reports of laparoscopy in populations with a high 
median or mean BMI, ≥35 [5,8­10] or ≥30 [11­16] and the pre­
cise influence of BMI on complication rates and on the surgery 
performed within these series has not been clearly delineated. 
Our objective was to analyze experience with laparoscopy 
and la  pa  rotomy for EC within an obese population to deter­
mine the effect of BMI on postoperative complications and 
the performance of lymph node dissection (LND).
MATERIALS AND METHODS
This was a retrospective cohort study. After approval of the 
In  s  titutional Review Board all women undergoing sur  gi  cal 
treat  ment for EC within a Cancer Center­based gyne  co  lo  gic 
on  co  logy service between November 2003 and De  cem  ber 
2008 were identified. Relevant medical records were retrie  v­
ed between June 2009 and December 2010. Follow­up was 
either in the Cancer Center or nearer to home. Where ne  ce­
ssa  ry follow­up information was obtained from the hospital 
tu  mor registry or from patients in person. Histology details 
were obtained from the surgical pathology reports and tumor 
conference records. For analysis, high­risk histologic subtypes 
(serous, clear cell or mixed containing serous or clear cell) 
were grouped together under serous, whereas endometrioid 
histology included endometrioid with mucinous elements. 
Surgery was performed by four gynecologic oncologists 
within a residency training program. The decision to perform 
la  pa  ro  scopy or laparotomy was by surgeon preference but 
by the end of the study period all patients with clinically early 
stage disease (confined to the uterus) were selected for la­
pa  ro  scopy provided that they were considered capable of 
tolerating the procedure. Laparotomy utilized either a midline 
or low transverse incision, with panniculectomy in a minority 
to fa  ci  litate surgery. The decision to perform a LND was based 
on prognostic factors (grade of primary tumor, depth of myo­
metrial invasion, size of primary tumor) and the feasibility of 
surgery based on the patient’s medical condition and body 
habitus. LND was preferred for tumors of grade 3, grade 1 and 
2 with outer half myometrial invasion, and tumors with obvi­
ous cervical involvement, spread outside the uterus or of high 
risk (serous, clear cell) subtype.
The laparoscopic technique of obtaining entry to the perito­
neal cavity most commonly consisted of direct entry using a 5 
mm Optiview port (Ethicon Endosurgery, Cincinnati, OH, USA) 
in the left upper quadrant of the abdomen followed by place­
ment of a 10 mm camera port at the umbilicus, 5 mm ports 
in both iliac fossa and a 10 mm port suprapubically. Surgical 
specimens were normally removed through the vagina whilst 
larger specimens were removed using an extended port inci­
sion. Lymph node (LN) were removed in a bag through a 10 
mm port or the vagina. Laparoscopic hysterectomy was early 
on performed by laparoscopic­assisted vaginal hyste  rectomy 
(LAVH) and later by total laparoscopic hysterectomy (TLH) and 
robotic­assisted (TRH) (Intuitive Surgical Inc., Sunnyvale, CA, 
USA) with the entire procedure performed from above. For 
the laparoscopic approach it was standard practice to use a 
RUMI uterine manipulator (CooperSurgical Inc, Trumbull, CT, 
USA).
For analysis, patients were divided into two groups: those 
treated by laparotomy and those in whom the intention was 
to perform the surgery laparoscopically. Patients were classi­
fied as having their surgery ‘converted’ to laparotomy when­
ever laparoscopy was discontinued so that surgery could be 
completed through a laparotomy incision or an extension 
of a regular port incision to remove the uterus. BMI was cal­
culated using the formula BMI=weight (kg)/[height (m)]
2. A 
presumptive FIGO stage based on the parameters available 
was assigned to patients who did not undergo complete sur­
gical staging. All adverse events were recorded and divided 
into intra­operative and postoperative within two months of 
surgery. Postoperative complications were graded according 
to the National Cancer Institute Common Toxicity Criteria for 
Adverse Events grading system (CTCAE ver. 4.03) [17]. The 
degree of wound pain was recorded as present or absent. 
Wound separation included wounds that opened spontane­
ously and those that were opened in order to assist healing. 
Analysis was performed by the ‘intention to treat’ basis. 
1. Statistical methods 
The distributions for patient characteristics and different 
com  pli  cations between laparoscopy and laparotomy groups 
were compared using the Wilcoxon rank sum test for con­
tinuous variables and χ²­test (or Fisher’s exact test when the 
expected frequency within any cell was less than 5 in a 2×2 
table) for categorical variables (Tables 1 and 2). Given that the 
impact of BMI on outcome variables was very important, we 
grouped patients into broad BMI groups (BMI ≥36 or BMI<36), 
using the median cut­off criterion. In each of the surgery 
approaches, the association between BMI class (BMI ≥36 or 
BMI<36) and different lymph node dissec  tions (any LND, para­C. William Helm, et al.
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aortic LND [PALND] and pelvic LND [PLND]) were estimated 
using Fisher’s exact test within stage I and for all stages (Table 
3). Due to the ordinal patients’ cha  rac  teristics (such as age, 
surgery duration), we used Fisher’s Z trans  for  mation before 
calculating Pearson correlation between BMI and other char­
acteristics (Table 4) [18]. Within each surgery approach, we 
used logistic regression models to explore the effect of BMI 
on complications and we use a superscript * to identify signifi­
Table 1. Patient characteristics by surgical approach (n=168)
Variables Laparoscopy (n=65) Laparotomy (n=103) Total (n=168) p-value
Age (yr) 57 (27-83) 59 (30-89) 58 (27-89) 0.78
 <50 19 (29.2) 22 (21.4) 41 (24.4) 0.23
 50-65 23 (35.4) 50 (48.5) 73 (43.5)
 ≥65 23 (35.4) 31 (30.1) 54 (32.1)
Race, white 61 (93.8) 98 (95.1) 159 (94.6) 0.74
BMI  35.0 (19.3-60.6) 37.5 (18.1-72.7) 36.2 (18.1-72.7) 0.07
 <36 36 (55.4) 47 (45.6) 83 (49.4) 0.23
 ≥36 29 (44.6) 56 (54.4) 85 (50.6)
LND at laparotomy 7 (10.8)
Stage of disease
 IA 17 (26.6) 26 (25.2) 43 (25.7) 0.24
 IB 32 (50.0) 46 (44.7) 78 (46.7) 0.17*
 IC 8 (12.5) 7 (6.8) 15 (9.0) 0.02
†
 II 5 (7.8) 10 (9.7) 15 (9.0)
 III 2 (3.1) 10 (9.7) 12 (7.2)
 IV 0 (0.0) 4 (3.9) 4 (2.4)
Grade of disease
 I 32 (49.2) 51 (49.5) 83 (49.4) 0.81
 II 22 (33.8) 31 (30.1) 53 (31.5)
 III 11 (16.9) 21 (20.4) 32 (19.0)
Histology
 Endometrioid 60 (92.3) 97 (94.2) 157 (93.5) 0.75
 Serous 5 (7.7) 6 (5.8) 11 (6.5)
Other procedure 2 (3.1) 24 (23.3) 26 (15.5) <0.01
Previous abdominal surgery 24 (36.9) 29 (28.2) 53 (31.5) 0.21
LND performed  23 (35.4) 46 (44.7) 69 (41.1) 0.23
 PALND performed 19 (29.2) 34 (33.0) 53 (31.5) 0.61
 PLND performed 21 (32.3) 46 (44.7) 67 (39.9) 0.11
No. of LN 17 (3-38) 14 (0-46) 16 (0-46) 0.22
No. of PALN 7 (4-20) 5 (0-14) 5 (0-20) <0.01
No. of PLN 14 (5-28) 11 (1-37) 13 (1-37) 0.76
Duration of surgery (min) 265 (120-480) 210 (75-360) 231 (75-480) <0.01
Estimated blood loss (mL) 100 (10-600) 200 (50-2500) 200 (10-2500) <0.01
Duration of hospital stay (day) 2 (1-12) 4 (2-18) 4 (1-18) <0.01
Time to flatus (day) 2 (1-9) 4 (1-10) 3 (1-10) <0.01
Postoperative Hb 11.1 (8.6-14.4) 10.8 (7.4-14.4) 11.0 (7.4-14.4) 0.04
Values are presented as number (%) or median (range). 
BMI, body mass index; LND, lymph node dissection; PALND, para-aortic lymph node dissection; PLND, pelvic lymph node dissection; FIGO, 
International Federation of Obstetrics and Gynecology; PALN, para-aortic lymph nodes; PLN, pelvic nodes; Hb, hemoglobin.
*IA vs. IB vs. IC vs. II vs. III or higher. 
†I or II vs. III or higher.BMI and surgery for endometrial cancer
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Table 2. Distribution of complications by surgical approach and conversion to laparotomy (n=168)
Variables
Laparoscopy converted to laparotomy Laparotomy 
(n=103) p-value
‡
No (n=53) Yes (n=12) p-value
Intra-operative complication 4 (7.5) 0 (0.0) 0.59 4 (3.9) 0.71
Complications any grade* 25 (47.2) 10 (83.3) 0.02 76 (73.8) 0.01
Complication, grade ≥3 2 (3.8) 4 (33.3) 0.01 35 (34.0) <0.01
Peri operative mortality 1 (1.9) 0 (0.0) 1.00 2 (1.9) 1.00
Wound any kind 6 (11.3) 5 (41.7) 0.02 52 (50.5) <0.01
Wound
† 0 (0.0) 2 (16.7) 0.03 23 (22.3) <0.01
Wound pain 5 (9.4) 0 (0.0) 0.58 23 (22.3) 0.01
Wound infection
† 0 (0.0) 2 (16.7) 0.03 21 (20.4) 0.01
Wound separation 0 (0.0) 2 (16.7) 0.03 27 (26.2) <0.01
Pulmonary
† 1 (1.9) 0 (0.0) 1.00 2 (1.9) 1.00
Venous thrombo-embolism
† 0 (0.0) 0 (0.0) 0.63 2 (1.9) 0.52
Head
† 0 (0.0) 0 (0.0) 0.63 3 (2.9) 0.28
Gastro-intestinal
† 0 (0.0) 0 (0.0) 0.63 1 (1.0) 1.00
Cardiac
† 1 (1.9) 2 (16.7) 0.09 3 (2.9) 0.68
Renal
† 0 (0.0) 1 (8.3) 0.19 0 (0.0) 0.39
Vagina 2 (3.8) 0 (0.0) 1.00 3 (2.9) 1.00
Reoperation 0 (0.0) 0 (0.0) 0.49 6 (5.8) 0.08
Anemia
† 0 (0.0) 0 (0.0) 0.63 5 (4.9) 0.16
Postoperative transfusion 0 (0.0) 3 (25.0) 0.01 14 (13.6) 0.06
Due to small cell frequency, some of the p-values are not reliable.
*Does not include patients reporting wound pain. 
†Grade ≥3. 
‡Laparoscopy vs. laparotomy.
Table 3. Distribution and test of association between lymph node dissection and BMI using logistic regression
Type of dissection Stage of disease
Laparoscopy Laparotomy
BMI < 36 BMI ≥ 36 p-value BMI < 36 BMI ≥ 36 p-value
Lymph node dissection IA 4/8 1/9 0.13 4/11 3/15 0.41
IB 6/16 1/16 0.08 9/18 10/28 0.37
IB or IC 12/23 2/17 0.02 10/20 13/33 0.57
Total all stages 18/36 5/29 0.01* 26/47 20/56 0.05*
Para-aortic LND IA 4/8 1/9 0.13 1/11 0/15 0.42
IB 5/16 1/16 0.17 7/18 8/28 0.53
IB or IC 10/23 2/17 0.04 8/20 11/33 0.77
Total all stages 15/36 4/29 0.03* 20/47 14/56 0.09
Pelvic LND IA 4/8 1/9 0.13 4/11 3/15 0.41
IB 5/16 1/16 0.17 9/18 10/28 0.37
IB or IC 11/23 1/17 <0.01 10/20 13/33 0.57
Total all stages 17/36 4/29 <0.01* 26/47 20/56 0.05*
The subgroup analysis may not be reliable due to the small sample size.
BMI, body mass index; LND, lymph node dissection.
*Indicates variables significantly associated with BMI≥36 vs. BMI<36 in logistic regression model at alpha=0.05. C. William Helm, et al.
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cant results in Tables 3.
The Kaplan­Meier method [19] was used to estimate the 
overall survival (OS) and progression free survival (PFS). Sur­
vival differences were compared using the un­weighted log­
rank test [20]. The OS time was determined as the time from 
surgery until death or last follow­up evaluation. The PFS time 
was determined as the time from surgery until the first ad­
verse event (i.e., disease progression, second malignancy, or 
death due to any cause). All calculations were performed with 
SAS (SAS Institute Inc., Cary, NC, USA) [21]. 
RESULTS
Between November 2003 and December 2008, 168 women 
underwent surgery for EC (103 laparotomy and 65 laparo  sco­
py). In the laparoscopy group 13 (20%) underwent LAVH, 33 
(50.7%) TLH, 8 (12.3%) TRH and 4 (6.1%) TAH after conversion 
to laparotomy whilst 7 (10.8%) had had a prior hys  te  rectomy. 
Of the laparoscopic cases, 41 (63%) were per  formed by one 
sur  geon (CWH) and 24 (37%) by the three other surgeons 
with the number of cases and ex  peri  ence increasing for all 
sur  geons over time, 19 (29%) being per  formed in the years 
2003­2006 and 46 (71%) 2007­2008. Patient characteristics by 
surgical approach are given in Table 1. The median BMI was 
36.2 (range, 18.1 to 72.7). There was no difference between 
the two groups with regard to age, race, BMI, histologic sub­
type or grade of disease or in the percentage undergoing LND 
(either PALND or PLND or both) in either group: 23/65 (35.4%) 
laparoscopy and 46/103 (44.7%) laparotomy (p=0.23). Twelve 
of 65 (18.5%) originally taken to the operating room with the 
intent to perform laparoscopy were converted to laparotomy 
for the following reasons and with associated BMI: extensive 
adhesions (n=3) 21.3, 22.9, 29.3, to complete staging (n=2) 
32.9, 35.1, to remove a large uterus (n=3) 41.0, 56.2, 59.7, inad­
equate exposure due to subperitoneal fat (n=1) 24.2, and un­
able to tolerate ‘head down’ position or pneumoperitoneum 
(n=3) 31.3, 51.6, 60.6. Two patients had a combination of fac­
tors leading to conversion BMI 60.64 and 31.3.
Significantly more patients in the laparotomy group unde­
r  went additional procedures other than hysterectomy and/or 
BSO, PALND, or PLND (Table 1): 24/103 (23.3%) versus 2/65 (3%) 
(p<0.01). In the laparotomy group, the 29 additio  nal procedures 
performed in 24 patients were: partial omentectomy (n=10), 
hernia repair (n=6), panniculectomy (n=3), small bowel re­
section (n=2), appendectomy (n=2), colostomy repair (n=1), 
omental J flap (n=1), liver biopsy (n=1), colposacropexy (n=1), 
and urethral sling procedure and upper vaginectomy (n=1). 
In the laparoscopy group, the additional procedures were 
urethral sling procedure (n=1) and umbilical hernia repair 
(n=1). There was no significant difference in the proportion 
of pa  tients undergoing previous abdominal surgery in the la­
pa  ro  scopy and laparotomy groups (24/65 [36.9%] vs. 29/103 
[28.2%]; p=0.21) and none of these were for cancer. 
The median number of PALN removed was greater in the 
la  pa  ro  scopy versus laparotomy group but there was no diffe­
ren  ce in the median number of pelvic LN (PLN), or overall 
number of LN removed (Table 1). 
Estimated blood loss, time to flatus, and duration of hospital 
stay were less in the laparoscopy group whilst the duration of 
surgery was longer (Table 1). After laparotomy the postopera­
tive hemoglobin (Hb) was lower than after laparoscopy (Table 
1). There were no port­site metastases and no vaginal dehis­
cences in the laparoscopy group. Four non­severe intra­oper­
ative complications occurred in each group. In the laparotomy 
group they were: colotomy repaired primarily and protected 
with omental J flap, bleeding from the inferior vena cava (n=2) 
and hypotension whilst in the laparoscopy group they were: 
bladder muscular injury repaired, bleeding from epigastric 
artery caused by the suturing device at closure, small vaginal 
tear while removing large uterus and hypercarbia causing 
temporary interruption of the procedure. There were 3 peri­
operative deaths, one after laparoscopy (sudden collapse at 
home on postoperative day 8 with cause of death given as 
cardiac arrest) and two after laparotomy (one a cardiac ar­
Table 4. Correlation between body mass index and continuous cha-
rac  teristics by surgical approach
Characteristics
Laparoscopy Laparotomy
ρ ˆ p-value ρ ˆ p-value
Patient no. 65 103
Age -0.354 <0.01 -0.441 <0.01
Surgery duration 0.003 0.98 0.196 0.04
Estimated blood loss 0.130 0.30 0.099 0.32
Duration of hospital stay -0.021 0.88 -0.005 0.96
Time to flatus -0.092 0.46 -0.152 0.12
Postoperative Hb -0.228 0.07 -0.062 0.54
PALN total 0.054 0.83 -0.378 0.03
PLN total 0.096 0.68 -0.012 0.94
Lymph node total 0.233 0.30 -0.155 0.32
Hb, hemoglobin; PALN, para-aortic lymph nodes; PLN, pelvic lymph 
nodes.
ρ ˆ  is a correlation coefficient determined using the Pearson 
correlation test by Fisher’s z transformation.  ρ ˆ >0 indicates the 
variable increases as BMI increases (e.g., surgery duration at 
laparotomy) and  ρ ˆ <0 indicates the variable decreases as BMI 
increases (e.g., PALN total when performed at laparotomy).  ρ ˆ =0 
indicates there is no correlation.BMI and surgery for endometrial cancer
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rest on postoperative day 4 and the other sudden collapse at 
home on postoperative day 47). No post mortems were per­
formed. 
Complications of any grade excluding pain and grade ≥3 
com  plications were significantly more common after la  pa  ro­
tomy (p=0.01, p≤0.01) Table 2. Only two patients ex  peri  en  ced 
grade ≥3 complications after undergoing the entire procedure 
laparoscopically, one pneumonia and the other su  dden death 
at home postoperative day 8. Although there was no signifi­
cant difference in the incidence of postoperative anemia ≥3, 
14 (13.6%) received a postoperative trans  fusion after laparoto­
my versus 3 (4.6%) after laparoscopy (p=0.06) with all 3 being 
converted to laparotomy (Table 2). Wound complications and 
complications of any kind ≥3 were significantly more com­
mon in the 12 patients in the laparoscopy group who were 
converted to laparotomy com  pared to the 53 patients in the 
laparoscopy group who under  went surgery without conver­
sion. In contrast, there was no diffe  rence in these complica­
tions between the 12 patients con  verted from laparoscopy 
to laparotomy and the 103 pa  tients in the laparotomy group 
(Table 2). Six (5.8%) patients in the laparotomy group under­
went a further operative pro  cedure, 5 wound debridements 
and one colostomy for a recto­vaginal fistula. No patients in 
the laparoscopy group needed a further surgery (p=0.08). 
Analysis of the correlation between BMI and continuous 
characteristics by surgical approach (Table 4) showed that in 
the laparoscopy group increasing BMI did not impact the du­
rations of surgery or hospital stay, time to flatus or number of 
PALN and PLN removed nor the estimated blood loss, whereas 
it was associated with a trend towards a lower postoperative 
Hb level (p=0.07). In the laparotomy group increasing BMI was 
associated with longer duration of surgery and lower number 
of PALN removed. 
In a logistic model to examine the effect of BMI (≥36 and<36) 
on complications within the laparotomy and laparoscopy 
groups, there was no relationship between complications and 
BMI within the laparoscopy group. In contrast, in the laparo­
tomy group, wound complications of any kind (p<0.01), grade 
≥3 wound (p≤0.01), grade ≥3 wound infection (p=0.01) and 
wound separation (p=0.02) were all significantly related to 
BMI. 
In the laparoscopy group within stage I (Table 3) there was 
an inverse relationship between the performance of LND of 
any kind (p=0.01), PALND (p=0.03), and PLND (p<0.01) and in­
creasing BMI in contrast to the laparotomy group where there 
was a trend only. 
The overall median follow­up time from surgery was 17.2 
months and 17.4 months for patients who were alive at the 
time of the last follow­up. For FIGO stage I (Table 5), OS and 
PFS were similar between groups (p=0.12, p=0.39) after me­
dian follow­up of 12.8 months (range, 0 to 59.3 months). As 
expected with the higher incidence of patients with FIGO 
stage ≥ II the OS was worse in the laparotomy group (data not 
shown). 
DISCUSSION 
The key results in this study are that increasing BMI signifi­
cantly impacted the decision to perform LND in patients 
under  going laparoscopic surgery but it did not impact post­
operative morbidity. The report contains a population with a 
high median and mean BMI (35.0 and 36.0) with over 50% in 
both the laparoscopy and laparotomy groups being obesity 
class II or greater according to the World Health Organization 
International Classification of Obesity in which BMI ≥30 (over­
weight), 30­34.99 (class I), 35­39.99 (class II), and ≥40 (class III) 
[22]. In contrast to laparotomy, many reports of laparoscopy 
for EC either specifically exclude women with high BMI [23] or 
the local populations have a low prevalence of obesity [24]. 
Studies reporting the use of laparoscopy for EC where the me­
dian or mean BMI are ≥30 are detailed in Table 6. 
We classified the complications of surgery according to the 
CTCAE ver. 4.03 [17]. Only one other study has used an earlier 
version of this grading system [23] which standardizes the 
reporting of complications and facilitates comparisons and 
Table 5. Overall survival and progression free survival probability for FIGO stage I by surgical approach
Type Approach
No. of 
patients
Survival percentage and standard error
p-value 1-yr 2-yr 3-yr 4-yr 5-yr
% SE % SE % SE % SE % SE
OS Laparoscopy 59 98.2 2.0 98.2 3.1 98.2 3.6 98.2 5.9 98.2 9.3 0.12
Laparotomy 79 96.1 2.5 94.4 4.1 90.1 7.3 77.2 21.3 77.2 36.9
PFS Laparoscopy 59 100 0.0 100 0.0 100 0.0 100 0.0 100 0.0 0.39
Laparotomy 79 100 0.0 97.6 2.8 97.6 3.9 97.6 8.7 97.6 15.1
FIGO, International Federation of Obstetrics and Gynecology; SE, standard error; OS, overall survival; PFS, progression free survival.C. William Helm, et al.
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statistical analysis. The uni  ver  sal ado  p  tion of this system in 
future would avoid the diffi  cul  ties of com  paring complication 
rates when either no [5,6,8,12­14,16,25­36], subjective [15,24] 
or institutional [9] classi  fi  ca  tions are used. Its use should be 
encouraged. 
In our series overall complications occurring during and after 
laparoscopy surgery were not related to the BMI. Two reports 
amongst the few in the literature that include populations 
with a high median or mean BMI ≥35 [5,8­10] or ≥30 [11­16] 
(Table 6) came to a similar conclusion [13,14] although an­
other reported an increase in complications within a sub  set of 
patients having age>65 years, weight >80 kg, a BMI>30 with 
at least one of the following co­morbidities: dia  betes, hyper­
tension or cardio­respiratory failure [11]. The overall lack of re­
lationship between BMI and complications after laparoscopy 
for EC is in marked distinction to patients undergoing laparot­
omy where patients with BMI ≥36 have a significantly greater 
incidence of wound complications including severe infection, 
wound separation and likelihood of postoperative transfusion. 
This association is well known in patients undergoing lapa­
rotomy for benign conditions and EC [32]. Since the greatest 
benefits from laparoscopy are seen in patients with high BMI 
we agree with others that it should be the initial approach of 
choice for such patients [11,32]. 
Our conversion rate of 18.5% is high in relation to some 
recent studies (Table 6) but is within the literature range of 
0­36.4% [5,8,9,11­13,16,23,25­28,30­35,37,38]. This is almost 
certainly due to the learning curve since in 6 of the cases (ad­
hesions [n=3], for staging [n=2], inadequate exposure due to 
subperitoneal fat [n=1]), conversion would probably now be 
avoided as a result of increased experience. This would reduce 
the complete conversion rate (excluding laparotomy to re­
move large uteri) to 3 of 65 = 4.6% which would include those 
with obesity­related problems such as inability to tolerate the 
head down position and pneumoperitoneum. Of note is that, 
in this series, patients who were converted to laparotomy 
from laparoscopy had complications similar to those under­
going planned laparotomy (Table 2). 
Childers et al. [39] was the first to report that obesity was 
the limiting factor in performing LND among women with EC. 
In our series, performance of both PALND and PLND was in­
versely related to the BMI (Table 3). In series containing popu­
lations with high median or mean BMI (Table 6) there was re­
ported to be no influence overall [13] or no influence on PLND 
specifically [6]. With regard to PALND, Tozzi et al. [6] reported 
‘minimal influence’ and Scribner et al. [8] suggested that there 
was ‘probably’ an effect on PALND because of difficulties in 
access in obese patients, backed up by a conversion rate of 
36.4% with the commonest reason being obesity. Eltabbakh 
et al. [5] reported that 5% of patients did not undergo PALND 
due to ‘lack of exposure’. Others have reported the increased 
difficulty in performing PALND with increasing weight [30] 
and when the weight is >160 kg [32]. Even in papers that do 
not report on the impact of BMI on the performance of LND 
it is possible to infer an effect of BMI by examining the rate 
of conversion and the reasons for conversion. In the recent 
Gynecologic Oncology Group study the conversion rate was 
25.8% of 1,682 patients randomized to undergo laparoscopy 
Table 6. Reports of laparoscopy for endometrial cancer with median or mean BMI≥30
Author year Type No. BMI median (range) BMI mean (range) Conversion (%) PALND (%) PLND (%) Any LND (%)
Eltabbakh 2000 [5] P 40 - 35.8 (28.9-55) 7.5 7.5 60 67.5
Scribner 2002 [8] R 55 - 40 (28-61.7) 36.4 100 100 100
Tozzi 2005 [11] RAN 63 - 31.3 (20.2-43.6) 7.9 60.3 84 -
O’Hanlan 2005 [12] R 76
59
- 30.5, SD 8.9 1.3 - - 28
O’Hanlan 2006 [13] R 90
64
- 30.2 (18-60.7) 3.3 30 30 30
Eisenhauer 2007 [9] R 25 39 (35-49) - 16 36 40 40
Gehrig 2008 [14] R 32 - 32 (30-55) 9.4 90.6 87.5 94
Bell 2008 [15] R 30 - 31.9, SD 9.8 - 100 100 100
Eisenkop 2010 [16] R 210 30.2 (16.6-65.5) 31.4, SD 8.69 4.7 100 100 100
Fanning 2010 [10] P 235 - 39 (22-77) 3 17.8 100 100
Current series R 65 35.0 (19.3-60.6) 36.0 (33.4-38.6)* 18.5 32.3 33.8 35.4
BMI, body mass index; PALND, para-aortic lymph node dissection; PLND, pelvic lymph node dissection; LND, lymph node dissection; P, 
prospective; R, retrospective; RAN, randomized; SD, standard deviation; CI, confidence interval.
*95% confidence interval.BMI and surgery for endometrial cancer
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for staging of clinical stage I to IIA EC. Conversion occurred in 
26.5% of patients with BMI 34­35 and 57.1% with BMI>40 [23]. 
However, it appears that the technical difficulties of PALND 
in the obese can be overcome and three studies (Table 6) 
reported rates of PALND of 90­100% [14­16] with low rates of 
conversion to laparotomy 9.4% and 4.7% [14,16] indicating 
that PALND is feasible in the majority of this population. BMI 
probably played a role in the performance of PALND because 
the reason for conversion in 2 of 10 patients in one study was 
inadequate exposure due to adhesions and obesity [16].
This report clearly has significant limitations in that it was 
retrospective, it included patients treated with LAVH, TLH, and 
TRH performed during transition from laparotomy to laparos­
copy surgery for EC within a gynecologic oncology group of 
4 surgeons, and it included no prospective analysis of pain or 
quality of life. However, these do not negate the significant 
findings that the BMI did not affect the rate of complications 
within the group undergoing laparoscopy, or the number of 
LN removed when a LND was performed. With regard to as­
sessing the influence of the BMI on the decision to perform 
a LND, there were no mandated criteria for performance of 
LND or contemporary documentation of the reasoning be­
hind the decision whether or not to perform LND but there 
was a group consensus with regards to the factors indicating 
the need for LND. This supports the finding that the decision 
whether or not to perform LND was, in part, related to the 
BMI of the patient. This has previously been only alluded to in 
other series including populations with a high BMI [5,8,30­32]. 
The question arises as to how to manage patients with a 
high BMI who are at increased risk for LN metastasis due to 
factors such as poor grade and deep myometrial invasion, 
cervical involvement and high­risk histologic subtypes. In 
such patients access to the para­aortic nodal bed is essential 
and presents more of a problem in these patients than pelvic 
node dissection. The data in this series applies only to the per­
formance of transperitoneal LND and it may be that in such 
patients an extraperitoneal approach may give more reliable 
access to the para­aortic nodes up to the left renal vein and 
duodenum. 
Within our experience, for patients undergoing laparoscopic 
surgery for EC, increasing BMI did not impact postoperative 
complications or number of LN resected. However, the BMI 
did influence the decision to perform LND at laparoscopy. 
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